IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,347,000 | -2.4% | 201,038 | +11.9% | 0.00% | 0.0% |
| Q4 2021 | $3,430,000 | -73.8% | 179,666 | -66.2% | 0.00% | -71.4% |
| Q3 2021 | $13,089,000 | +88.4% | 530,781 | +98.8% | 0.01% | +75.0% |
| Q2 2021 | $6,947,000 | +16.1% | 266,999 | +41.2% | 0.00% | +33.3% |
| Q1 2021 | $5,985,000 | +2.0% | 189,034 | +49.5% | 0.00% | -25.0% |
| Q4 2020 | $5,866,000 | +60.6% | 126,416 | +13.9% | 0.00% | +33.3% |
| Q3 2020 | $3,653,000 | -10.7% | 110,965 | -25.5% | 0.00% | 0.0% |
| Q2 2020 | $4,090,000 | +22.0% | 149,016 | +33.0% | 0.00% | 0.0% |
| Q1 2020 | $3,353,000 | +38.6% | 112,003 | +28.1% | 0.00% | +50.0% |
| Q4 2019 | $2,420,000 | +53.7% | 87,417 | +1.0% | 0.00% | +100.0% |
| Q3 2019 | $1,575,000 | -25.6% | 86,557 | +0.3% | 0.00% | -50.0% |
| Q2 2019 | $2,117,000 | +917.8% | 86,318 | +293.9% | 0.00% | – |
| Q1 2019 | $208,000 | +5.1% | 21,913 | -2.1% | 0.00% | – |
| Q4 2018 | $198,000 | -3.9% | 22,391 | +22.1% | 0.00% | – |
| Q3 2018 | $206,000 | +0.5% | 18,337 | +14.3% | 0.00% | – |
| Q2 2018 | $205,000 | -88.2% | 16,043 | -84.4% | 0.00% | -100.0% |
| Q1 2018 | $1,735,000 | +1214.4% | 102,638 | +521.0% | 0.00% | – |
| Q4 2017 | $132,000 | +3.1% | 16,527 | +0.3% | 0.00% | – |
| Q3 2017 | $128,000 | +2.4% | 16,478 | -3.2% | 0.00% | – |
| Q2 2017 | $125,000 | – | 17,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |